These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711 [TBL] [Abstract][Full Text] [Related]
5. Chemotactic activity in periodontal disease. I. The role of complement in monocyte chemotaxis. Okada H; Silverman MS J Periodontal Res; 1979 Jan; 14(1):20-5. PubMed ID: 153959 [No Abstract] [Full Text] [Related]
6. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)]. Pham Huu T; Buriot D; Griscelli C Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417 [TBL] [Abstract][Full Text] [Related]
10. Monocyte count, monocyte chemotaxis and chemotactic factor inactivator in gastric cancer patients. Yamane T; Sakita M; Kasuga M; Nishioka B; Fujita Y; Majima S Jpn J Surg; 1981; 11(6):422-7. PubMed ID: 7328934 [TBL] [Abstract][Full Text] [Related]
11. [Changes in the functions of polymorphonuclear granulocytes in the etiopathogenesis of periodontal disease]. Guida L; Belardo S Arch Stomatol (Napoli); 1986; 27(3):423-30. PubMed ID: 3477150 [No Abstract] [Full Text] [Related]
12. [Methods of study and the mechanism of chemotaxis and spontaneous migration of phagocytes in vitro]. Hermanowicz A Acta Haematol Pol; 1981; 12(3-4):197-205. PubMed ID: 7044020 [No Abstract] [Full Text] [Related]
13. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)]. Nakayama M Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510 [TBL] [Abstract][Full Text] [Related]
14. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Miller MD; Krangel MS Crit Rev Immunol; 1992; 12(1-2):17-46. PubMed ID: 1418604 [TBL] [Abstract][Full Text] [Related]
15. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8. Zachariae CO Acta Derm Venereol Suppl (Stockh); 1993; 181():1-37. PubMed ID: 7901957 [TBL] [Abstract][Full Text] [Related]
16. Disorders of human leukocyte chemotaxis. Lohr KM; Snyderman R Clin Immunol Rev; 1981; 1(1):67-118. PubMed ID: 6762275 [No Abstract] [Full Text] [Related]
18. Extracts of airborne grain dusts activate alternative and classical complement pathways. Olenchock SA; Mull JC; Major PC Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283 [TBL] [Abstract][Full Text] [Related]
19. Depression of blood monocytes chemotaxis in human chronic Chagas disease. Ferreira GG; Argueles E; Oliveira-Lima A Rev Inst Med Trop Sao Paulo; 1979; 21(6):297-301. PubMed ID: 121632 [No Abstract] [Full Text] [Related]
20. Participation of the complement system in ischemia/reperfusion injury. Rubin B; Smith A; Romaschin A; Walker P Microcirc Endothelium Lymphatics; 1989; 5(3-5):207-21. PubMed ID: 2637943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]